Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 4, 2006, Pages 438-446

  Wuestemeyer, Henrike ^a   Sauerwein, Wolfgang ^a   Meller, Daniel ^a   Chauvel, Pierre ^b   Schueler, Andreas ^a   Steuhl, Klaus Peter ^a   Bornfeld, Norbert ^a   Anastassiou, Gerasimos ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Conjunctival melanoma; Exenteration; Proton raiotherapy; Recurrence; Therapy

Indexed keywords

ARTIFICIAL TEAR;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RISK; CATARACT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONJUNCTIVA TUMOR; DEATH; EVISCERATION; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTON THERAPY; RECURRENT CANCER; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; VISUAL ACUITY;

ADOLESCENT; AGED; AGED, 80 AND OVER; CONJUNCTIVAL NEOPLASMS; DOSE FRACTIONATION; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROTONS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33645786079     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0093-5     Document Type: Article

References (33)

1. van der Aardweg GJMJ, Naus NC, Verhoeven ACA, de Klein A, Luyten GPM (2002) Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines. Investig Ophthalmol Vis Sci 43:2561-2565
2. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP (2002) Prognostic value of clinical and histopathological parameters in conjunctival melanomas: A retrospective study. Br J Ophthalmol 86:163-167
3. Anderson DF, Ellies P, Pires RTF, SCG Tseng (2001) Amniotic membrane transplantation for partial limbal stem cell deficiency: Long term outcomes. Br J Ophthalmol 85:354-361
4. Chauvel P, Caujolle J, Sauerwein W, Friedrichs W, Brassart N, Herault J (1994) Protontherapy as a possible salvage treatment for conjunctival melanomas. Frezotti R, Balestrazzi E, Flaco L, Esente S (ed) Monduzzi Editore, Bologna. 177-181
5. Chauvel P, Sauerwein W, Bornfeld N, Friedrichs W, Brassart N, Coupland SE, Herault J, Pignol JP, Bondiau PY, Malandain G (1997) Clinical and technical requirements for proton treatment planning of ocular disease. The SERAG (South European Radiotherapy Group). Front Radiat Ther Oncol 30:133-142
6. Foss AJ, Whelehan I, Hungerford JL et al (1997) Predictive factors for the development of rubeosis following proton beam radiotherapyfor uveal melanoma. Br J Ophthalmol 81:748-754
7. Fuchs U, Kivela T, Liesto K, Tarkkanen A (1989) Prognosis of conjunctival melanomas in relation to histophatological features. Br J Cancer 59(2):261-267
8. Gragoudas ES, Egan KM, Walsh SM et al (1995) Lens changes after protonbeam irradiation for uveal melanoma. Am J Ophthalmol 119:157-164
9. Guyer DR, Mukai S, Egan KM et al (1992) Radiation macolopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 99:1278-1285
10. Heimann H, Coupland SE, Gochman R, Hellmich M, Foerster MH (2001) Alterations in expression of mucin, tenascin-c and syndecan-1 in the conjunctivafollowing retinal surgery and plaque radiotherapy. Graefe Arch Clin Exp Ophthalmol 239:488-495
11. Koch JM, Bornfeld N, Waubke TN, Wessing A (1988) Impression cytology of the conjunctiva after high dose brachytherapy of malignant melanomas of the uvea with 106 Ru/ 106 Rh-Plaques. Fortschr Ophthalmol 85:642-645
12. Kubo M, Sonoda Y, Maramatsu R, Usui M (2001) Immunogenicity of human amniotic membrane in experimental xenotransplantation. Investig Ophthalmol Vis Sci 42:1539-1546
13. Lommatzsch PK (1978) Beta ray treatment of malignant epibulbar melanoma. Graefe Arch Clin Exp Ophthalmol 209(2):111-124
14. Lommatzsch PK, Lommatzsch R, Kirsch I, Fuhrmann P (1990) Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 74:615-619
15. Lommatzsch PK, Werschnik C (2002) Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow up. Klin Monatsbl Augenheilkd 219(10):710-721
16. Lumbroso L, Desjardin L, Levy C, Plancher C, Frau E, D'Hermies F, Schlienger P, Mammar H, Delacroix S, Nauraye C, Ferrand R, Desblancs C, Mazal A, Asselain B (2001) Intraocular inflammation after proton beam irradiation for uveal melanoma. Br J Ophthalmol 85:1305-1308
17. Meller D, Pires RF, Tseng SCG (2002) Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br J Ophthalmol 86:463-471
18. Missotten GS, Keijser S, Keizer RJWD, Wolff-Rouendaal DD (2005) Conjunctival melanoma in the Netherlands: A nationwide study. Investig Ophthalmol Vis Sci 46:75-82
19. Norregaard JC, Gerner N, Jensen OA, Prause JU (1996) Malignant melanoma of the conjunctiva: Occurrence and survival following surgery and radiotherapy in a Danish population. Graefe Arch Clin Exp Ophthalmol 234(9):569-572
20. Paridaens AD, McCartney AC, Minassian DC, Hungerford JL (1994) Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol 78(7):520-528
21. Paridaens AD, Minassian DC, MacCarty CA, Hungerford JL (1994) Prognostic factors in primary malignant melanoma of the conjunctiva: A clinicopathological study of 256 cases. Br J Ophthalmol 78(4):252-259
22. Paridaens D, Beekhuis H, van Den Bosch W, Remeyer L, Melles G (2001) Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 85(6):658-661
23. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, JanaJan N, Lipsett J (1991) Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20(3):429-432
24. Selek U, Chang EL, Hassenbusch SH III, Shiu A, Lang FF, Allen P, Weinberg J, Sawaya R, Maorm H (2004) Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 59(4):1097-1106
25. Shields CL (2000) Conjunctival melanoma: Risk factors for recurrences, exenteration, metastasis and death in 150 consecutive patients. Trans Am Ophthalmol Soc 98:471-492
26. Suit H (2003) Protons to replace photons in external beam radiation therapy. Clin Oncol (R Coll Radiol) 15(1):S29-S31
27. Suit H, Urie M (1992) Proton beams in radiation therapy. J Natl Cancer Inst 84(3):155-164
28. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116:431-441
29. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shimazaki J (1996) Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122:38-52
30. Tuomaala S, Eskelin S, Tarkkanen A, Kivela T (2002) Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Investig Ophthalmol Vis Sci 43:3399-3408
31. Vongtama R, Safa A, Gallardo D, Calcaterra T, Juillard G (2003) Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck 25:423-428
32. Wada H, Nemoto K, Ogawa Y, Hareyama M, Yoshida H, Takamura A, Ohmori K, Hamamoto Y, Sugita T, Saotoh M, Yamada S (2004) A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 59(2):495-500
33. Werschnik C, Lommatzsch PK (2002) Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 25(3):248-255